Advent Capital Management’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX.PRA
Advent Capital Management's BSX.PRA Position: Q1 2023 in Review
Advent Capital Management held its Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) position steady in Q1 2023 at 0 shares worth $4.81M. The position accounts for 0.09% of the portfolio, ranked #142.
Advent Capital Management first reported a position in BSX.PRA in Q2 2020 and has held it in 6 quarters since. The position peaked at $38.8M in Q4 2021. 56 funds tracked by Wall St. Rank hold BSX.PRA as of Q1 2023.
- Advent Capital Management held 0 shares of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A worth $4.81M as of Q1 2023.
- Advent Capital Management left its Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A share count unchanged in Q1 2023.
- Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A made up 0.09% of Advent Capital Management's portfolio in Q1 2023, its #142 holding.
- Advent Capital Management first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q2 2020 and has held it in 6 quarters since.
- Advent Capital Management's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $38.8M in Q4 2021.
- 56 funds tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q1 2023.
Based on Advent Capital Management's 13F filing for Q1 2023, filed 12 May 2023.